| MEDICATION Classes | ADHD Medication Name | FORMULATION | COMPOUND | DURATION | DOSING CONSIDERATIONS | SAVINGS PROGRAM |
|---|---|---|---|---|---|---|
| METHYLPHENIDATE | Adhansia XR® | Extended-release capsule | Capsule with multilayer beads; 20% immediate-release layer and 80% controlled-release layer | 12 hours or more | Capsule may be opened and contents swallowed completely with applesauce | N/A |
| METHYLPHENIDATE | (Adlon Therapeutics) | 25 mg, 35 mg, 45 mg. 55 mg, 70 mg, 85 mg | ||||
| METHYLPHENIDATE | Aptensio XR® | Extended-release capsule | Capsule with multilayer beads; 40% of dose in the immediate-release layer and 60% in the extended-release layer (2nd peak at 7–8 hrs) | 12 hours | Capsule may be opened and contents swallowed completely with applesauce | YES |
| METHYLPHENIDATE | (Rhodes Pharmaceuticals) | 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg | ||||
| METHYLPHENIDATE | Concerta® or generic* | Extended-release tablet | Tablet with OROS osmotic pump technology; biphasic release with initial peak at 1 hr (22% of dose) and 78% gradual release over 9 hrs. Only Patriot version is authorized for substitution for brand at pharmacy. | 12 hours | Must be swallowed whole; non-absorbable shell may be passed in stool | YES |
| METHYLPHENIDATE | (Janssen and others) | 18 mg, 27 mg, 36 mg, 54 mg | ||||
| METHYLPHENIDATE | Cotempla XRODT™ | Extended-release orally disintegrating tablet | Dissolving tablet with 25% immediate-release microparticles and 75% extended-release | 12-13 hours | Grape-flavored, allow to dissolve in saliva | YES |
| METHYLPHENIDATE | (NEOS Therapeutics) | 8.6 mg, 17.3 mg, 25.9 mg | ||||
| METHYLPHENIDATE | Daytrana® | Transdermal patch | Drug dispersed in adhesive layer; applied daily | 9 hour wear-time | The time worn can be varied to control the duration of effects; monitor for skin rash or sensitivity. Discard patches appropriately. Slow onset of medication over initial six hours. | YES |
| METHYLPHENIDATE | (Noven Therapeutics) | 10 mg, 15 mg, 20 mg, 30 mg | ||||
| METHYLPHENIDATE | JORNAY PM™ | Delayed release – Extended release capsule | Dual-layer delexis delivery: outer layer delays release for up to 10 hours, inner layer controls daytime release | 12 – 14 hours | Taken before going to sleep to provide early morning symptom control | YES |
| METHYLPHENIDATE | (Ironshore Pharmaceuticals) | 20mg, 40mg, 60mg, 80mg, 100mg | ||||
| METHYLPHENIDATE | Metadate CD® | Extended-release capsule | Diffucaps capsule with 30% immediate-release beads and 70% delayed-release beads* | 8-10 hours | Capsule may be opened and contents swallowed completely with applesauce | |
| METHYLPHENIDATE | (UCB, Inc.) | 10 mg, 20 mg, 30 mg 40 mg, 50 mg, 60 mg | ||||
| METHYLPHENIDATE | Methylphenidate HCI | Chewable tablet | Methylphenidate HCl | 3-4 hours | Grape-flavored chewable tablet | |
| METHYLPHENIDATE | (Lupin) | 2.5 mg, 5 mg, 10 mg | ||||
| METHYLPHENIDATE | Methylphenidate HCl | Extended-release tablet* | Methylphenidate HCl | 6-8 hours | Swallow whole; do not crush or chew | |
| METHYLPHENIDATE | (Mallinckrodt Pharmaceuticals) | 10 mg, 20 mg | ||||
| METHYLPHENIDATE | Methylin™ Liquid or generic | Oral solution | Methylphenidate HCl | 3-4 hours | Colorless, grape-flavored liquid; store at room temperature | |
| METHYLPHENIDATE | (Shionogi Pharma and others) | 5 mg/5 mL, 10 mg/5 mL | ||||
| METHYLPHENIDATE | Quillichew ER™ | Extended-release chewable tablet | 30% of the dose is immediate-release and 70% extended-release | 8 hours | Cherry-flavored; may be taken with or without food | YES |
| METHYLPHENIDATE | (Tris Pharmaceuticals) | 20 mg, 30 mg, 40 mg | ||||
| METHYLPHENIDATE | Quillivant XR® | Extended-release oral suspension | 20% of the dose is immediate-release and 80% extended-release | 12 hours | Fruit-flavored; may be taken with or without food. Shake bottle for at least 10 seconds. May be stored at room temperature | YES |
| METHYLPHENIDATE | (Tris Pharmaceuticals) | 25 mg/5 mL | ||||
| METHYLPHENIDATE | Ritalin® or generic | Short-acting, immediate- | Methylphenidate HCl | 3-4 hours | Abrupt onset and offset increase the number and severity of side effects | |
| METHYLPHENIDATE | (Novartis and others) | release tablet | ||||
| METHYLPHENIDATE | 5 mg, 10 mg, 20 mg | |||||
| METHYLPHENIDATE | Ritalin LA® | Extended-release capsule | Capsule with Spheroidal Oral Drug Absorption System (SODA S) technology; 50% immediate-release beads and 50% delayed-release (2nd peak 4 hrs later)* | 8-12 hours | Capsule may be opened and contents swallowed completely with applesauce | |
| METHYLPHENIDATE | (Novartis) | 10 mg, 20 mg, 30 mg, 40 mg, 60 mg | ||||
| METHYLPHENIDATE | Ritalin SR® | Sustained-release tablet | Methylphenidate HCl | 8 hours | Tablets should be swallowed whole, never crushed or chewed | |
| METHYLPHENIDATE | (Novartis) | 20 mg | ||||
| DEXMETHYLPHENIDATE | Focalin® or generic | Short-acting, immediate- | Dexmethylphenidate Hydrochloride | 4-6 hours | Isolated active dextroisomer; give approximately 1/2 methylphenidate dose | |
| DEXMETHYLPHENIDATE | (Novartis and others) | release tablet* | ||||
| DEXMETHYLPHENIDATE | 2.5 mg, 5 mg, 10 mg | |||||
| DEXMETHYLPHENIDATE | Focalin XR® or generic | Extended-release capsule | Capsule with SODA S technology; 50% of the beads contained in the capsule are immediate-release and 50% are delayed-release* | 8-12 hours | Capsule may be opened and beads swallowed completely with applesauce | YES |
| DEXMETHYLPHENIDATE | (Novartis and others) | 5 mg, 10 mg, 15 mg, 20 mg, 25 mg, 30 mg, 35 mg, 40 mg | ||||
| AMPHETAMINE | Adzenys ER™ | Extended-release oral suspension | 50% immediate-release and 50% delayed-release particles | 10-12 hours | Orange-flavored; may be taken with or without food. Shake bottle vigorously before dispensing the dose. | YES |
| AMPHETAMINE | (Neos Therapeutics) | 1.25 mg/ml | ||||
| AMPHETAMINE | Adzenys XR-ODT™ | Extended-release orally disintegrating tablet | Dissolving tablet with 50% immediate-release and 50% delayed-release particles | 10-12 hours | Allow tablet to dissolve in saliva. | YES |
| AMPHETAMINE | (Neos Therapeutics) | 3.1 mg, 6.3 mg, 9.4 mg, 12.5 mg, 15.7 mg, 18.8 mg | ||||
| AMPHETAMINE | Dyanavel® XR | Extended-release oral suspension | Oral solution with bubblegum flavor | 13 hours | Bubblegum flavor; may be taken with or without food. Shake bottle before preparing the dose. May be stored at room temperature | YES |
| AMPHETAMINE | (Tris Pharma) | 2.5 mg/ml | ||||
| DEXTROAMPHETAMINE | Dexedrine® | Short-acting tablet | Dextroamphetamine Sulfate | 3-4 hours | Take first dose on awakening | |
| DEXTROAMPHETAMINE | (Amedra Pharmaceuticals and others) | 5 mg, 10 mg | ||||
| DEXTROAMPHETAMINE | Dexedrine ER® | Extended-release spansule | Dextroamphetamine Sulfate delivered in a sustained-release spansule. Initial dose released immediately, remaining medication released gradually. | 5-10 hours | ||
| DEXTROAMPHETAMINE | (Amedra Pharmaceuticals and others) | 5 mg, 10 mg, 15 mg | ||||
| ProCentra® and generic | (Independence Pharma, Tris Pharma, and others) | 5 mg/5 mL | ||||
| ProCentra® and generic | Zenzedi® | Immediate-release tablet 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg, 20 mg, 30 mg | Dextroamphetamine Sulfate | 4-6 hours | Take first dose on awakening | YES |
| ProCentra® and generic | (Arbor Pharmaceuticals) | 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg, 20 mg, 30 mg | Dextroamphetamine Sulfate | 4-6 hours | Take first dose on awakening | |
| METHAMPHETAMINE | Desoxyn® | Immediate-release tablet | Methamphetamine | 4-6 hours | ||
| (Recordati Rare Diseases and others) | 5 mg | |||||
| MIXED AMPHETAMINE SALTS | Adderall® or generic | Short-acting, immediate-release tablet | Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate | 4-6 hours | May be taken with or without food | |
| MIXED AMPHETAMINE SALTS | (CorePharma and others) | 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg, 20 mg, 30 mg | ||||
| MIXED AMPHETAMINE SALTS | Adderall® XR or generic | Extended-release capsule | Capsule with Microtrol delivery system: 50% immediate-release and 50% delayed-release beads* | 10-12 hours | Capsule may be opened and beads swallowed whole with applesauce | |
| MIXED AMPHETAMINE SALTS | (Takeda and others) | 5 mg, 10 mg, 15 mg, 20 mg, 25 mg, 30 mg | ||||
| MIXED AMPHETAMINE SALTS | Mydayis® | Long-acting capsule | Long-acting, triple-bead, mixed amphetamine salts formulation | 14-16 hours | Capsule may be opened and beads swallowed whole with applesauce | YES |
| MIXED AMPHETAMINE SALTS | (Takeda) | 12.5 mg, 25 mg, 37.5 mg, 50 mg | ||||
| AMPHETAMINE SULFATE | Evekeo® | Immediate-release tablet | 50 percent dextroamphetamine and 50 percent levoamphetamine | 4-6 hours | YES | |
| AMPHETAMINE SULFATE | (Arbor Pharmaceuticals) | 5 mg, 10 mg | ||||
| LISDEXAMFETAMINE | Vyvanse® | Long-acting capsule | Lisdexamfetamine Dimesylate; peaks in 3.5 hrs* | 10-13 hours | Capsule may be opened and contents dissolved in water, yogurt, or orange juice; use immediately after dissolving | YES |
| LISDEXAMFETAMINE | (Takeda) | 10 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg, 70 mg | ||||
| LISDEXAMFETAMINE | Vyvanse® | Chewable tablet | Lisdexamfetamine Dimesylate; peaks in 3.5 hrs* | 10-13 hours | Strawberry flavored; may be taken with or without food | |
| LISDEXAMFETAMINE | (Takeda) | 10 mg, 20 mg, 30mg, 40 mg, 50 mg, and 60 mg | ||||
| LISDEXAMFETAMINE | ||||||
| ATOMOXETINE | Strattera® and generics | Long-acting capsule | All day atomoxetine | 24 hours | Selective norepinephrine inhibitor. Starts working in a few days to one week, but may take several weeks to achieve full effect. Swallow capsule whole; powder is irritating. Dose is commonly divided in two to lower side effects | YES |
| ATOMOXETINE | (Lilly) | 10 mg, 18 mg, 25 mg, 40 mg, 60 mg, 80 mg, 100 mg | ||||
| CLONIDINE | Kapvay® and generic clonidine ER | Extended-release tablet | Clonidine Hydrochloride. | 24 hours | Swallow tablet whole | |
| CLONIDINE | (Advanz Pharmaceuticals) | 0.1 mg, 0.2 mg | ||||
| GUANFACINE | Intuniv™ or generic | Extended-release tablet | Guanfacine | 24 hours | Swallow tablet whole; a high-fat meal may increase absorption and lead to toxicity. FDA -approved for doses up to 7 mg | YES |
| GUANFACINE | (Takeda and others) | 1 mg, 2 mg, 3 mg, 4 mg | ||||
| BUPROPION | Wellbutrin XL® | Extended-release tablet | Bupropion HCL | 24 hours | Low efficacy; takes 8 weeks to fully develop benefits. IR dosed 3 times a day; SR dosed 2 times/day; XL dosed once a day. | YES |
| (Valeant Pharmaceuticals) | 150mg, 300mg |
ADHD Medications
Published: Mar 1, 2021 by Scott Fisher by Scott Fisher